Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma

Fig. 2

miR-17-5p promotes cell cycle progress in HNSCC in vitro. (A) AMC-HN8 cells and FaDu cells were transfected with miR-17-5p inhibitor or inhibitor NC. Tu686 cells and Detriot562 cells were transfected with miR-17-5p mimic or mimic negative control (NC). Cell cycle phase distribution was detected by flow cytometry. Data shown are the mean ± standard deviation of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 vs. inhibitor NC or mimic NC. (B) Cell cycle-related genes were detected by qRT-PCR. *p < 0.05, **p < 0.01, ***p < 0.001 vs. inhibitor NC or mimic NC

Back to article page